June 26, 2011

New vaccine technologies to prevent Cervical Cancer

Vaccines to Prevent Cervical Cancer

Cervical cancer is the second most common cancer in women in Asia and more deri half of Asian women who develop cervical cancer will die from the disease. In Asia, every 4 minutes a woman dies from cervical cancer. Cervical cancer is caused by the human papillomavirus (HPV) causes cancer saati has been able to in vaccination. Every woman is at risk of cervical cancer throughout his life. By kaena that a vaccine specifically designed to protect women from cervical cancer represents a breakthrough in science and is good news for women everywhere.
Not All the Same Vaccine Technology. Since HPV infections that have occurred will not trigger the formation of a full natural immunity and the occurrence of re-infection is common.

It is particularly important when a vaccine that targets a cancer-causing HPV types can stimulate a strong immune response and stable. Ongoing research has shown that adjuvant system No. 4 (AS04) used in the development of new cervical cancer vaccine for teenage girls and adult women will stimulate a strong immune response and stable compared to traditional aluminum adjuvant.
Findings from the research provided by health experts showed that the vaccine that uses antibodies tinddi AS04 showed against HPV types 16 and 18 (which is responsible for more than 70% of cervical cancer in the world), in women who are vaccinated with a wide age range of 10 years up to 55 years and 100% protection for 5.5 years against HPV types 16 and 18 are associated with precancerous lesions that lead to cervical cancer.
Associated with this new technology, Dr. Hariyono Winarto, SpOG said, \ "The results of several studies conducted by the manufacturer in collaboration with world renowned independent scientists have supported the AS04 provides a higher immune response and increase duration / length of protection caused by it. In layman's language, adjuvant is valid as a booster, to help establish a higher immune response and durable compared with the same vaccine formulated with aluminum hydroxide only just. Development of a vaccine to prevent cancer is one of the greatest success achieved by preventive medicine.
The new cervical cancer vaccine for teenage girls and adult women would help provide a strong immune response and stable against HPV types 16 and 18 are responsible for more than 70.7% of cases of cervical cancer in Asia.

New vaccine technologies to prevent Cervical Cancer

Vaccines to Prevent Cervical Cancer

Cervical cancer is the second most common cancer in women in Asia and more deri half of Asian women who develop cervical cancer will die from the disease. In Asia, every 4 minutes a woman dies from cervical cancer. Cervical cancer is caused by the human papillomavirus (HPV) causes cancer saati has been able to in vaccination. Every woman is at risk of cervical cancer throughout his life. By kaena that a vaccine specifically designed to protect women from cervical cancer represents a breakthrough in science and is good news for women everywhere.
Not All the Same Vaccine Technology. Since HPV infections that have occurred will not trigger the formation of a full natural immunity and the occurrence of re-infection is common.

It is particularly important when a vaccine that targets a cancer-causing HPV types can stimulate a strong immune response and stable. Ongoing research has shown that adjuvant system No. 4 (AS04) used in the development of new cervical cancer vaccine for teenage girls and adult women will stimulate a strong immune response and stable compared to traditional aluminum adjuvant.
Findings from the research provided by health experts showed that the vaccine that uses antibodies tinddi AS04 showed against HPV types 16 and 18 (which is responsible for more than 70% of cervical cancer in the world), in women who are vaccinated with a wide age range of 10 years up to 55 years and 100% protection for 5.5 years against HPV types 16 and 18 are associated with precancerous lesions that lead to cervical cancer.
Associated with this new technology, Dr. Hariyono Winarto, SpOG said, \ "The results of several studies conducted by the manufacturer in collaboration with world renowned independent scientists have supported the AS04 provides a higher immune response and increase duration / length of protection caused by it. In layman's language, adjuvant is valid as a booster, to help establish a higher immune response and durable compared with the same vaccine formulated with aluminum hydroxide only just. Development of a vaccine to prevent cancer is one of the greatest success achieved by preventive medicine.
The new cervical cancer vaccine for teenage girls and adult women would help provide a strong immune response and stable against HPV types 16 and 18 are responsible for more than 70.7% of cases of cervical cancer in Asia.